Cargando…

Return to work after cancer treatment of gynecologic cancer in Japan

BACKGROUND: Gynecologic cancer is one of the most common malignant diseases in working-age women. This study investigated whether several characteristics influence return to work after treatment of gynecologic cancer. METHODS: We investigated the correlations between return to work and several other...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakamura, Keiichiro, Masuyama, Hisashi, Nishida, Takeshi, Haraga, Junko, Ida, Naoyuki, Saijo, Masayuki, Haruma, Tomoko, Kusumoto, Tomoyuki, Seki, Noriko, Hiramatsu, Yuji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4966766/
https://www.ncbi.nlm.nih.gov/pubmed/27473230
http://dx.doi.org/10.1186/s12885-016-2627-0
_version_ 1782445429901754368
author Nakamura, Keiichiro
Masuyama, Hisashi
Nishida, Takeshi
Haraga, Junko
Ida, Naoyuki
Saijo, Masayuki
Haruma, Tomoko
Kusumoto, Tomoyuki
Seki, Noriko
Hiramatsu, Yuji
author_facet Nakamura, Keiichiro
Masuyama, Hisashi
Nishida, Takeshi
Haraga, Junko
Ida, Naoyuki
Saijo, Masayuki
Haruma, Tomoko
Kusumoto, Tomoyuki
Seki, Noriko
Hiramatsu, Yuji
author_sort Nakamura, Keiichiro
collection PubMed
description BACKGROUND: Gynecologic cancer is one of the most common malignant diseases in working-age women. This study investigated whether several characteristics influence return to work after treatment of gynecologic cancer. METHODS: We investigated the correlations between return to work and several other characteristics in 199 gynecologic cancer survivors. Questionnaires were distributed to patients with cancer (≥1 year after treatment and age of <65 years) who visited Okayama University. Logistic regression analysis and receiver operating characteristic curves were used to determine whether each characteristic influenced return to work (no return to work or job change) in these gynecologic cancer survivors. RESULTS: For all patients, the mean age at the time of diagnosis was 47.0 years, and the average number of years after treatment was 4.5. Forty-four patients (53.7 %) who were non-regular employees continued to be employed at the same workplace. Non-regular employment had a significantly higher area under the curve (AUC) (0.726) than other characteristics in terms of negatively affecting return to work. Additionally, non-regular employment tended to have a higher AUC (0.618) than other characteristics in terms of job changes. CONCLUSIONS: Non-regular employment was the variable most likely to negatively affect return to work and job changes in employed patients who underwent treatment for gynecologic cancer.
format Online
Article
Text
id pubmed-4966766
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-49667662016-07-30 Return to work after cancer treatment of gynecologic cancer in Japan Nakamura, Keiichiro Masuyama, Hisashi Nishida, Takeshi Haraga, Junko Ida, Naoyuki Saijo, Masayuki Haruma, Tomoko Kusumoto, Tomoyuki Seki, Noriko Hiramatsu, Yuji BMC Cancer Research Article BACKGROUND: Gynecologic cancer is one of the most common malignant diseases in working-age women. This study investigated whether several characteristics influence return to work after treatment of gynecologic cancer. METHODS: We investigated the correlations between return to work and several other characteristics in 199 gynecologic cancer survivors. Questionnaires were distributed to patients with cancer (≥1 year after treatment and age of <65 years) who visited Okayama University. Logistic regression analysis and receiver operating characteristic curves were used to determine whether each characteristic influenced return to work (no return to work or job change) in these gynecologic cancer survivors. RESULTS: For all patients, the mean age at the time of diagnosis was 47.0 years, and the average number of years after treatment was 4.5. Forty-four patients (53.7 %) who were non-regular employees continued to be employed at the same workplace. Non-regular employment had a significantly higher area under the curve (AUC) (0.726) than other characteristics in terms of negatively affecting return to work. Additionally, non-regular employment tended to have a higher AUC (0.618) than other characteristics in terms of job changes. CONCLUSIONS: Non-regular employment was the variable most likely to negatively affect return to work and job changes in employed patients who underwent treatment for gynecologic cancer. BioMed Central 2016-07-29 /pmc/articles/PMC4966766/ /pubmed/27473230 http://dx.doi.org/10.1186/s12885-016-2627-0 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Nakamura, Keiichiro
Masuyama, Hisashi
Nishida, Takeshi
Haraga, Junko
Ida, Naoyuki
Saijo, Masayuki
Haruma, Tomoko
Kusumoto, Tomoyuki
Seki, Noriko
Hiramatsu, Yuji
Return to work after cancer treatment of gynecologic cancer in Japan
title Return to work after cancer treatment of gynecologic cancer in Japan
title_full Return to work after cancer treatment of gynecologic cancer in Japan
title_fullStr Return to work after cancer treatment of gynecologic cancer in Japan
title_full_unstemmed Return to work after cancer treatment of gynecologic cancer in Japan
title_short Return to work after cancer treatment of gynecologic cancer in Japan
title_sort return to work after cancer treatment of gynecologic cancer in japan
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4966766/
https://www.ncbi.nlm.nih.gov/pubmed/27473230
http://dx.doi.org/10.1186/s12885-016-2627-0
work_keys_str_mv AT nakamurakeiichiro returntoworkaftercancertreatmentofgynecologiccancerinjapan
AT masuyamahisashi returntoworkaftercancertreatmentofgynecologiccancerinjapan
AT nishidatakeshi returntoworkaftercancertreatmentofgynecologiccancerinjapan
AT haragajunko returntoworkaftercancertreatmentofgynecologiccancerinjapan
AT idanaoyuki returntoworkaftercancertreatmentofgynecologiccancerinjapan
AT saijomasayuki returntoworkaftercancertreatmentofgynecologiccancerinjapan
AT harumatomoko returntoworkaftercancertreatmentofgynecologiccancerinjapan
AT kusumototomoyuki returntoworkaftercancertreatmentofgynecologiccancerinjapan
AT sekinoriko returntoworkaftercancertreatmentofgynecologiccancerinjapan
AT hiramatsuyuji returntoworkaftercancertreatmentofgynecologiccancerinjapan